Nuveen Asset Management, LLC Aeglea Bio Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.5 - $2.66 $84,560 - $449,859	-169,120 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.87 - $4.77 $557 - $1,421	298 Added 0.18%	169,120 $425,000
Q4 2021 Feb 14, 2022	SELL	$3.5 - $8.42 $37,870 - $91,104	-10,820 Reduced 6.02%	168,822 $653,000
Q3 2021 Nov 12, 2021	SELL	$6.03 - $7.95 $27,912 - $36,800	-4,629 Reduced 2.51%	179,642 $1.34 Million
Q2 2021 Aug 16, 2021	BUY	$6.32 - $8.38 $166,848 - $221,232	26,400 Added 16.72%	184,271 $1.28 Million
Q1 2021 May 17, 2021	SELL	$6.76 - $8.57 $51,294 - $65,029	-7,588 Reduced 4.59%	157,871 $1.25 Million
Q4 2020 Feb 16, 2021	SELL	$7.02 - $9.83 $5,847 - $8,188	-833 Reduced 0.5%	165,459 $1.3 Million
Q3 2020 Nov 16, 2020	SELL	$6.51 - $9.33 $274,136 - $392,886	-42,110 Reduced 20.21%	166,292 $1.18 Million
Q2 2020 Aug 14, 2020	BUY	$4.01 - $11.04 $480,454 - $1.32 Million	119,814 Added 135.25%	208,402 $1.93 Million
Q1 2020 May 14, 2020	SELL	$3.51 - $8.48 $1,246 - $3,010	-355 Reduced 0.4%	88,588 $412,000
Q4 2019 Feb 14, 2020	SELL	$7.23 - $8.55 $354,776 - $419,548	-49,070 Reduced 35.55%	88,943 $680,000
Q3 2019 Nov 14, 2019	SELL	$6.42 - $9.0 $5,752 - $8,064	-896 Reduced 0.65%	138,013 $1.06 Million
Q2 2019 Aug 15, 2019	BUY	$6.1 - $8.78 $847,344 - $1.22 Million	138,909 New	138,909 $951,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.